RESEARCH TRIANGLE PARK – Drug giant GSK, which employs thousands of people across the Triangle, is expanding its research and development footprint in the U.S.

According to the Boston Globe, GSK has signed a lease for an additional 155,000 square foot addition at a building in Cambridge beginning in 2024. GSK already occupies 55,000 square feet in the building, according to the Globe.

Read more details at: